| Literature DB >> 27240990 |
Balasundaram Padmanabhan1, Shruti Mathur, Ramu Manjula, Shailesh Tripathi.
Abstract
The bromodomains and extra-terminal domain (BET) family proteins recognize acetylated chromatin through their bromodomains (BDs) and help in regulating gene expression. BDs are chromatin 'readers': by interacting with acetylated lysines on the histone tails, they recruit chromatin-regulating proteins on the promoter region to regulate gene expression and repression. Extensive efforts have been employed by scientific communities worldwide to identify and develop potential inhibitors of BET family BDs to regulate protein expression by inhibiting acetylated histone (H3/H4) interactions. Several small molecule inhibitors have been reported, which not only have high affinity but also have high specificity to BET BDs. These developments make BET family proteins an important therapeutic targets for major diseases such as cancer, neurological disorders, obesity and inflammation. Here, we review and discuss the structural biology of BET family BDs and their applications in major diseases.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27240990 DOI： 10.1007/s12038-016-9600-6
Source DB: PubMed Journal: J Biosci ISSN： 0250-5991 Impact factor: 1.826